Polivy 30 mg powder for concentrate for solution for infusion*

Company

Roche Registration GmbH

Active Ingredient

• Polatuzumab Vedotin

Dosage Form

Powder for concentrate for Solution for infusion

Legal Category

A - prescription, may not be renewed

Date of revision

09/2026

*Additional information is available within the SPC or upon request to the company